JACQUELINE SMALL: Open Payments
NPI 1407415615 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,611 in 77 payments from 22 companies in 2025. Trend: 2023 $2,035 · 2024 $2,061 · 2025 $1,611
Food & beverage: $1,543Education: $68
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $269 |
| Astellas Pharma US Inc | 8 | $183 |
| Otsuka America Pharmaceutical, Inc. | 8 | $176 |
| SANOFI-AVENTIS U.S. LLC | 4 | $109 |
| Janssen Pharmaceuticals, Inc | 4 | $99 |
| Sumitomo Pharma America, Inc. | 5 | $99 |
| PFIZER INC. | 4 | $88 |
| ABBVIE INC. | 4 | $74 |
| Lundbeck LLC | 3 | $73 |
| GlaxoSmithKline, LLC. | 3 | $62 |
Products named: REXULTI, Wegovy, Veozah, TZIELD, SPRAVATO, GEMTESA, Ozempic, NURTEC ODT.
Industry payments across GA — which companies pay providers there.
